SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-000651
Filing Date
2020-01-29
Accepted
2020-01-29 16:19:18
Documents
4
Period of Report
2020-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_012920.htm 8-K 31886
2 PRESENTATION BY THE COMPANY ex99-01.htm EX-99.01 9709
3 PRESS RELEASE OF THE COMPANY, DATED JANUARY 29, 2020 ex99-02.htm EX-99.02 19371
4 GRAPHIC ex99-01_img001.jpg GRAPHIC 513746
  Complete submission text file 0001387131-20-000651.txt   769905
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20558387
SIC: 2834 Pharmaceutical Preparations